FDA launches pilot program in support of complex trial designs for drugs and biologics
The FDA announced a new pilot program Wednesday aimed at encouraging the use of complex innovative trial designs in the development of drugs and biologics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.